Form 4: Taysha Gene Therapies Director Alison S. Long Reports Acquisition and Disposal of Shares and Stock Options
SEC Form 4 Filing
Director Alison S. Long reports acquisition and disposal of Taysha Gene Therapies shares and stock options related to restricted stock units and stock options vesting on May 29, 2025, or the next annual stockholders meeting.
Summary
- On May 29, 2024, Alison S. Long, a director of Taysha Gene Therapies, reported acquiring 49,220 shares of common stock as a restricted stock unit (RSU) award.
- These RSUs will vest on the earlier of May 29, 2025, or the next annual stockholders meeting, contingent upon continued service as a director.
- Long also reported acquiring 98,440 stock options with an exercise price of $3.17, which also vest on the earlier of May 29, 2025, or the next annual stockholders meeting, subject to continued service as a director.
- The expiration date for these stock options is May 29, 2034.
- Long also disposed of 49,220 shares of common stock and 98,440 stock options.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing, so the sentiment is neutral. It reflects standard compensation practices and insider transactions.
Future Outlook
The vesting of the RSUs and stock options is contingent upon the reporting person's continued service as a director.
Industry Context
Form 4 filings are standard disclosures required by the SEC for company insiders, providing transparency into their transactions in the company's securities. This filing indicates changes in Alison S. Long's holdings in Taysha Gene Therapies.
Stakeholder Impact
- The filing provides transparency to shareholders regarding the transactions of a company director.
Key Dates
| Date | Description |
|---|---|
| 05/29/2024 | Date of transaction: Acquisition of shares and stock options. |
| 05/29/2025 | Vesting date for RSUs and stock options (or next annual stockholders meeting). |
| 05/29/2034 | Expiration date for stock options. |
| 05/31/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.